- Pen injectors
- Auto-injectors
- Prefilled syringes
- Wearable injectors
- Needle-free Injectors
Subcutaneous drug delivery market size was valued at USD 20.6 billion in the year 2022 and is anticipated to grow at USD 45.53 billion till 2029, witnessing a CAGR of around 12% from 2023 to 2029. The Subcutaneous drug delivery system is a workable alternative for intravenous administration system. Fast development of biologics gives rise to the use of subcutaneous drug delivery. The use of this system is mainly preferred due to its benefits such as improves quality of life, allows self-medication and consequently lessens healthcare costs. A few major factors contribute towards the growth of the global subcutaneous drug delivery market are expediency and protection provided by this system for medical experts and patients. Several health experts are suffered from infectious illnesses in 2014 as a consequent of needle stick wounds according to World Health Organization and this unique system works effectively to lessen the prevalence of needle stick damages. Subcutaneous drugs are given in the skin’s layer named cutis, which contains the dermis and epidermis. There are several pharmaceutical products developed and sold to treat different illnesses which are given through subcutaneous routes. The report gives a comprehensive outlook on subcutaneous drug delivery market across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Bn) on the basis of product, distribution Channel and region. This report studies global subcutaneous drug delivery market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in global subcutaneous drug delivery.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
There are many significant factors that contribute towards the growth of the subcutaneous drug deliver market and implementation of inorganic growth strategies by industry players is one of that. Key players focus more on inorganic strategies to give that important place to their products in the market. Growing focus on protecting the needle stick damage is given, which lead towards the growth of the market. Needle stick damages with lacing systems and injection needled are a major anxiety among diabetes patients. Growing alertness about safety and concern about needle stick damages are main factors booming the subcutaneous drug deliver market growth. The unavailability of the approved products because of rising number of product recalls by different developers is a market restricting factor.
2022 is the base year and 2029 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Subcutaneous Drug Delivery Market size was valued at USD 20.6 billion in the year 2022 and is anticipated to grow at USD 45.53 billion till 2029.
Subcutaneous Drug Delivery Market is poised to grow at a significant 12% from 2023 to 2029.
Asia Pacific is the fastest-growing for Subcutaneous Drug Delivery Market
1.Executive Summary |
2.Global Subcutaneous Drug Delivery Market Introduction |
2.1.Global Subcutaneous Drug Delivery Market - Taxonomy |
2.2.Global Subcutaneous Drug Delivery Market - Definitions |
2.2.1.Product |
2.2.2.Distribution Channel |
2.2.3.Region |
3.Global Subcutaneous Drug Delivery Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Subcutaneous Drug Delivery Market Analysis, 2018-2022 and Forecast 2023-2029 |
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Subcutaneous Drug Delivery Market By Product, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
5.1. Pen injectors |
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Auto-injectors |
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Prefilled syringes |
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Wearable injectors |
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Needle-free Injectors |
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
6.Global Subcutaneous Drug Delivery Market By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
6.1. Online pharmacies |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Hospital pharmacies |
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Retail pharmacies |
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7.Global Subcutaneous Drug Delivery Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.North America Subcutaneous Drug Delivery Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
8.1. Product Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Pen injectors |
8.1.2.Auto-injectors |
8.1.3.Prefilled syringes |
8.1.4.Wearable injectors |
8.1.5.Needle-free Injectors |
8.2. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Online pharmacies |
8.2.2.Hospital pharmacies |
8.2.3.Retail pharmacies |
8.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9.Europe Subcutaneous Drug Delivery Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
9.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Pen injectors |
9.1.2.Auto-injectors |
9.1.3.Prefilled syringes |
9.1.4.Wearable injectors |
9.1.5.Needle-free Injectors |
9.2. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Online pharmacies |
9.2.2.Hospital pharmacies |
9.2.3.Retail pharmacies |
9.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
9.3.6.Rest of EU |
10.Asia Pacific (APAC) Subcutaneous Drug Delivery Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
10.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Pen injectors |
10.1.2.Auto-injectors |
10.1.3.Prefilled syringes |
10.1.4.Wearable injectors |
10.1.5.Needle-free Injectors |
10.2. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Online pharmacies |
10.2.2.Hospital pharmacies |
10.2.3.Retail pharmacies |
10.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11.Middle East and Africa (MEA) Subcutaneous Drug Delivery Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Pen injectors |
11.1.2.Auto-injectors |
11.1.3.Prefilled syringes |
11.1.4.Wearable injectors |
11.1.5.Needle-free Injectors |
11.2. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Online pharmacies |
11.2.2.Hospital pharmacies |
11.2.3.Retail pharmacies |
11.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12.Latin America Subcutaneous Drug Delivery Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Pen injectors |
12.1.2.Auto-injectors |
12.1.3.Prefilled syringes |
12.1.4.Wearable injectors |
12.1.5.Needle-free Injectors |
12.2. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Online pharmacies |
12.2.2.Hospital pharmacies |
12.2.3.Retail pharmacies |
12.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.Gerresheimer AG |
13.2.2.Insulet Corporation |
13.2.3.Ypsomed AG |
13.2.4.Unilife Corporation |
13.2.5.West Pharmaceutical Services, Inc. |
13.2.6.Novo Nordisk |
13.2.7.Medtronic Plc |
13.2.8.Elcam Medical Group |
13.2.9.Becton, Dickinson and Company |
13.2.10.PharmaJet |
13.2.11.Inolife Sciences |
14. Research Methodology |
15. Appendix and Abbreviations |